Wormhole Capital
VC Fund
New York, United States
Wormhole Capital is a VC fund in New York focused on Health Care and Artificial Intelligence. Wormhole Capital is the investment arm of Vivek Garipalli’s family office that invests at any stage from seed to growth rounds. It backs deeply independent thinkers with audacious dreams and relentless determination.
- Total investments:
- 45
- Last investment:
- Lead investor:
- 7%
Last updated:
For AI agents: llms.txt
Industries Wormhole Capital invests in
Stages Wormhole Capital invests in
Countries Wormhole Capital invests in
Investment Focus
Industry
- Health Care 20 (44%)
- Artificial Intelligence 6 (13%)
- FinTech 5 (11%)
- Software 5 (11%)
- Biotechnology 5 (11%)
Stage
- Seed 14 (31%)
- Series A 9 (20%)
- Venture - Series Unknown 8 (18%)
- Series C 5 (11%)
- Series D 2 (4%)
Country
- United States 34 (76%)
- Brazil 2 (4%)
- Canada 1 (2%)
- France 1 (2%)
- Israel 1 (2%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
The American Baby Company
|
The American Baby Company provides fertility care focused on making fertility treatment more transparent, accessible, and patient-centered. | $4M / Seed / Jul 23, 2026 | |
Wagmo
|
Wagmo is a fantastic service that basically provides reimbursement for doing all the things that we already do to keep our dog. | Venture - Series Unknown / Jul 14, 2026 | |
Corner Health
|
Operator of a nurse practitioner management platform intended to empower nurses to start and manage their independent practices. | $25M / Series A / Jul 13, 2026 | |
Simuhealth
|
Simuhealth is a platform that helps simulation centers run more efficiently. It brings together everything you need to schedule sessions, manage equipment, track learners, and report on outcomes - all in one place. Instead of juggling spreadsheets, emails, and disconnected tools, simulation teams can use Simuhealth to coordinate day-to-dayoperations from a single, modern system. | $2.6M / Pre-Seed / Dec 08, 2025 | |
Ema
|
Ema is revolutionizing the way that women interact with technology by using data to create positive health outcomes from fertility to menopause. Our outcome data shows that our 100,000+ members have experienced countless health benefits, like an overall 84% reduction in loneliness, and a 75% reduction in anxiety. 96% of our medical experts findher accurate and reliable. Ema develops proprietary AI models that live in the technology of other companies (women's health resources, employers, and payors) | Convertible Note / Feb 29, 2024 | |
Heidi Health
|
Heidi Health develops an ambient AI medical scribe platform that automates clinical documentation and related tasks. It listens to patient-clinician conversations, transcribes key highlights, and then produces structured notes, referral letters, patient summaries, billing codes, and other downstream documents. The system supports customizabletemplates, allows editing during sessions, and integrates with various EHR systems while offering compliance with privacy and security standards. Clinicians in multiple specialties and care settings use Heidi to reduce administrative burden, improve focus on patient care, and streamline workflows. | $6.3M / Series A / Oct 25, 2023 | |
GlossGenius
|
GlossGenius is a company that creates automated personal assistant software for appointment management. The software from the company accepts bookings and payments, monitors clients and tracks their history, organizes personal calendars, and reports analytics, allowing beauty professionals and freelancers to manage and develop their companiesthrough client interaction and marketing automation. | $28M / Series C / Jul 27, 2023 | |
Ossium Health
|
Ossium is building the world's first bone marrow bank to treat blood cancers, improve organ transplantation, and repair damage from radiation.The cells of the immune system are the human body’s natural defenders against disease. At Ossium, they are developing better methods of recovering, preserving, deploying these critical cells to keepdisease at bay. | $52M / Series C / Jul 25, 2023 | |
Family First
|
Family First is the leader in ROI-based caregiving solutions as an employee and insurance benefit. Family First's expert-led and technology-enabled solution improves the health and well-being of caregivers and their loved ones, driving a direct impact on the quality and cost of care. | $11M / Series A / Jul 20, 2023 | |
Angle Health
|
Angle Health provides a technology-enabled health insurance platform to simplify employer-sponsored healthcare benefits. The company's service offers fully configurable group health plans that employers can tailor and deploy quickly through its “Benefit Builder” and “Quote-to-Card” tools, often eliminating the need for individual member-levelunderwriting. It integrates medical, pharmacy, demographic, claims, and population-health data with AI-enabled analytics to help employers, brokers, and care teams anticipate health needs and design plans accordingly.Angle Health’s plans typically include telemedicine, digital behavioral health, chronic-disease management, and access to a national network of doctors and providers—services that are often bundled into standard coverage. | $58M / Series A / Jan 25, 2023 | |
| See all 45 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Wormhole Capital invest in?
Wormhole Capital invests primarily in Health Care, Artificial Intelligence and FinTech startups, most often at Seed and Series A stage. Most of the 45 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Wormhole Capital last invest?
The most recent investment recorded for Wormhole Capital closed in Jul 2026. Shizune tracks 45 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
